Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes

The problematic and numerous side effects of PUVA (psoralen and UVA) and other treatments currently in use for vitiligo, have justified the search for an alternative treatment. In this study, the use of khellin, a naturally occurring furochromone, which is similar in structure to psoralens, is explo...

Full description

Saved in:
Bibliographic Details
Main Author: Carlie, Gadija
Other Authors: Kidson, Susan
Format: Thesis
Language:English
Published: Department of Human Biology 2018
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614331648081920
access_status_str Open Access
author Carlie, Gadija
author2 Kidson, Susan
author_browse Carlie, Gadija
Kidson, Susan
author_facet Kidson, Susan
Carlie, Gadija
author_sort Carlie, Gadija
collection Thesis
description The problematic and numerous side effects of PUVA (psoralen and UVA) and other treatments currently in use for vitiligo, have justified the search for an alternative treatment. In this study, the use of khellin, a naturally occurring furochromone, which is similar in structure to psoralens, is explored as an alternative treatment for vitiligo. When khellin is combined with UVA (KUVA), it is reported to repigment vitiligo skin as effectively as PUVA photochemotherapy, but without the adverse effects reported with PUVA. The exact mechanism for khellin-induced repigmentation is still to be determined and no cell biological studies have yet been done to elucidate its mechanism of action. The specific aim of this project was to set up an in vitro tissue culture system to determine the direct effects of khellin, UVA and KUVA on melanocyte proliferation and pigmentation. Studies were carried out on cultures of a human melanoma cell line (Mel-1), normal human melanocytes and 3T3 mouse fibroblasts. Cell proliferation assays revealed that the proliferation of melanoma cells and melanocytes were increased after exposure to khellin for four days at concentrations ranging from 1nM to 0.5mM. A peak of proliferation was obtained at 0.01mM khellin, which stimulated proliferation of melanoma cells and melanocytes by 2.3 5-fold and 2.1- fold, respectively. In contrast, khellin decreased proliferation of fibroblasts over the entire concentration range tested. At concentrations of 0.5mM and above, khellin was cytotoxic to both melanocytic cells and fibroblasts. Cytotoxic assays revealed that 1mM khellin was equally cytotoxic to both melanoma cells and fibroblasts. In addition, these assays revealed that the proliferative response observed with 0.01mM and 0.1mM khellin, did not mask an underlying cytotoxic effect. Exposure to single doses of UVA between 150-280mJ/cm², increased proliferation of melanoma cells with maximal proliferation at 250mJ/cm², while the proliferation of normal melanocytes and fibroblasts were unaffected by this UVA dose. More significantly than khellin or UVA alone, the treatment with the combination of khellin and UVA (KUVA) stimulated proliferation of the melanocytic cells. The combination of 0.01mM khellin plus a single dose of UVA at 250mJ/cm² was the most effective treatment. KUVA combination treatments were found to be more cytotoxic to the fibroblasts than khellin or UVA alone. To test the effect of khellin, UVA and KUVA on melanogenesis, standard radiometric assays were carried out. The combination of khellin and UVA enhanced melanogenesis of the melanocytic cells more significantly than khellin alone or UVA alone. The dose of 0.01mM khellin plus 250mJ/cm² UVA (maximal proliferative dose) increased melanogenesis of the melanocytes by 290% above the untreated control melanocytes. To determine whether khellin and KUVA act by increasing levels of melanogenic proteins, western blot analyses were carried out. The results revealed that there were no differences in the amounts of TRP-2 and tyrosinase in the melanocytic cells treated with khellin alone. In contrast, those treated with KUVA (or UVA alone) had increased levels of the glycosylated form of the enzymes and also possibly had increased levels of the de nova form of the enzymes. These results suggest that UVA might be enhancing glycosylation of melanogenic enzymes and provides a novel insight into the possible mechanism for UVA-induced melanogenesis. The results also revealed that 3T3 fibroblasts expressed the non-glycosylated form of TRP-2, as described by others. In conclusion, this study suggests a model in which khellin acts directly on melanocytic cells by acting as a mitogen and a melanogen at non-toxic concentrations. Khellin possibly increases melanogenesis by acting post-translationally or antagonizing or removing an inhibitor of the melanogenic pathway. The melanocyte-specific effect of khellin and even more so KUVA, seems to suggest that khellin acts along the signal transduction pathways which increases both proliferation and melanogenesis in melanocytes, possibly via endothelin-1 pathways.
format Thesis
id oai:open.uct.ac.za:11427/26931
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:50:21.044Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2018
publishDateRange 2018
publishDateSort 2018
publisher Department of Human Biology
publisherStr Department of Human Biology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/26931 An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes Carlie, Gadija Kidson, Susan Hulley, Phillipa Clinical Science and Immunology The problematic and numerous side effects of PUVA (psoralen and UVA) and other treatments currently in use for vitiligo, have justified the search for an alternative treatment. In this study, the use of khellin, a naturally occurring furochromone, which is similar in structure to psoralens, is explored as an alternative treatment for vitiligo. When khellin is combined with UVA (KUVA), it is reported to repigment vitiligo skin as effectively as PUVA photochemotherapy, but without the adverse effects reported with PUVA. The exact mechanism for khellin-induced repigmentation is still to be determined and no cell biological studies have yet been done to elucidate its mechanism of action. The specific aim of this project was to set up an in vitro tissue culture system to determine the direct effects of khellin, UVA and KUVA on melanocyte proliferation and pigmentation. Studies were carried out on cultures of a human melanoma cell line (Mel-1), normal human melanocytes and 3T3 mouse fibroblasts. Cell proliferation assays revealed that the proliferation of melanoma cells and melanocytes were increased after exposure to khellin for four days at concentrations ranging from 1nM to 0.5mM. A peak of proliferation was obtained at 0.01mM khellin, which stimulated proliferation of melanoma cells and melanocytes by 2.3 5-fold and 2.1- fold, respectively. In contrast, khellin decreased proliferation of fibroblasts over the entire concentration range tested. At concentrations of 0.5mM and above, khellin was cytotoxic to both melanocytic cells and fibroblasts. Cytotoxic assays revealed that 1mM khellin was equally cytotoxic to both melanoma cells and fibroblasts. In addition, these assays revealed that the proliferative response observed with 0.01mM and 0.1mM khellin, did not mask an underlying cytotoxic effect. Exposure to single doses of UVA between 150-280mJ/cm², increased proliferation of melanoma cells with maximal proliferation at 250mJ/cm², while the proliferation of normal melanocytes and fibroblasts were unaffected by this UVA dose. More significantly than khellin or UVA alone, the treatment with the combination of khellin and UVA (KUVA) stimulated proliferation of the melanocytic cells. The combination of 0.01mM khellin plus a single dose of UVA at 250mJ/cm² was the most effective treatment. KUVA combination treatments were found to be more cytotoxic to the fibroblasts than khellin or UVA alone. To test the effect of khellin, UVA and KUVA on melanogenesis, standard radiometric assays were carried out. The combination of khellin and UVA enhanced melanogenesis of the melanocytic cells more significantly than khellin alone or UVA alone. The dose of 0.01mM khellin plus 250mJ/cm² UVA (maximal proliferative dose) increased melanogenesis of the melanocytes by 290% above the untreated control melanocytes. To determine whether khellin and KUVA act by increasing levels of melanogenic proteins, western blot analyses were carried out. The results revealed that there were no differences in the amounts of TRP-2 and tyrosinase in the melanocytic cells treated with khellin alone. In contrast, those treated with KUVA (or UVA alone) had increased levels of the glycosylated form of the enzymes and also possibly had increased levels of the de nova form of the enzymes. These results suggest that UVA might be enhancing glycosylation of melanogenic enzymes and provides a novel insight into the possible mechanism for UVA-induced melanogenesis. The results also revealed that 3T3 fibroblasts expressed the non-glycosylated form of TRP-2, as described by others. In conclusion, this study suggests a model in which khellin acts directly on melanocytic cells by acting as a mitogen and a melanogen at non-toxic concentrations. Khellin possibly increases melanogenesis by acting post-translationally or antagonizing or removing an inhibitor of the melanogenic pathway. The melanocyte-specific effect of khellin and even more so KUVA, seems to suggest that khellin acts along the signal transduction pathways which increases both proliferation and melanogenesis in melanocytes, possibly via endothelin-1 pathways. 2018-01-24T11:50:32Z 2018-01-24T11:50:32Z 1999 Master Thesis Masters MSc (Med) http://hdl.handle.net/11427/26931 eng application/pdf Department of Human Biology Faculty of Health Sciences University of Cape Town
spellingShingle Clinical Science and Immunology
Carlie, Gadija
An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
thesis_degree_str Master's
title An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
title_full An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
title_fullStr An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
title_full_unstemmed An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
title_short An in vitro investigation of the effect of Khellin and UVA (KUVA) on normal and transformed human melanocytes
title_sort in vitro investigation of the effect of khellin and uva kuva on normal and transformed human melanocytes
topic Clinical Science and Immunology
url http://hdl.handle.net/11427/26931
work_keys_str_mv AT carliegadija aninvitroinvestigationoftheeffectofkhellinanduvakuvaonnormalandtransformedhumanmelanocytes
AT carliegadija invitroinvestigationoftheeffectofkhellinanduvakuvaonnormalandtransformedhumanmelanocytes